• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年银屑病关节炎:神话还是现实?一场无休止的辩论。

Juvenile Psoriatic Arthritis: Myth or Reality? An Unending Debate.

作者信息

Naddei Roberta, Rebollo-Giménez Ana, Burrone Marco, Natoli Valentina, Rosina Silvia, Consolaro Alessandro, Ravelli Angelo

机构信息

Dipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.

Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.

出版信息

J Clin Med. 2023 Jan 3;12(1):367. doi: 10.3390/jcm12010367.

DOI:10.3390/jcm12010367
PMID:36615167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9821505/
Abstract

Juvenile psoriatic arthritis (JPsA) accounts for 1-7% of all cases of juvenile idiopathic arthritis (JIA) and its definition has been a matter of controversy among pediatric rheumatologists for many years. The traditional attribution of JPsA to the spondyloarthropathy group was challenged in the early 1990s, whereas the recent demonstrations of its heterogenous nature have led to questions about its identification as a distinct category in JIA classification. It has been shown that children with the phenotype of JPsA can be divided in two subgroups, one presenting with the features of early-onset ANA-positive JIA, and another that belongs to the spectrum of spondyloarthropathies. The few studies that have compared the clinical characteristics and genetic determinants of JPsA with those of the other JIA categories have obtained contrasting findings. The debate on the categorization of JPsA as a distinct entity within JIA classification is still ongoing and has prompted the revision of its current classification.

摘要

幼年型银屑病关节炎(JPsA)占幼年特发性关节炎(JIA)所有病例的1%-7%,多年来其定义一直是儿科风湿病学家争论的焦点。20世纪90年代初,JPsA传统上归属于脊柱关节炎组的分类受到了挑战,而最近对其异质性本质的证明引发了关于在JIA分类中将其识别为一个独立类别的质疑。研究表明,具有JPsA表型的儿童可分为两个亚组,一个表现为早发性ANA阳性JIA的特征,另一个则属于脊柱关节炎谱系。少数将JPsA与其他JIA类别进行临床特征和遗传决定因素比较的研究得出了相互矛盾的结果。关于将JPsA归类为JIA分类中一个独立实体的争论仍在继续,并促使对其当前分类进行修订。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b35/9821505/7d8aa8865aed/jcm-12-00367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b35/9821505/7394690e666f/jcm-12-00367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b35/9821505/7d8aa8865aed/jcm-12-00367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b35/9821505/7394690e666f/jcm-12-00367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b35/9821505/7d8aa8865aed/jcm-12-00367-g002.jpg

相似文献

1
Juvenile Psoriatic Arthritis: Myth or Reality? An Unending Debate.青少年银屑病关节炎:神话还是现实?一场无休止的辩论。
J Clin Med. 2023 Jan 3;12(1):367. doi: 10.3390/jcm12010367.
2
The conundrum of juvenile psoriatic arthritis.青少年银屑病关节炎的难题。
Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S40-3. Epub 2015 Oct 15.
3
Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.青少年银屑病关节炎:来自GRAPPA 2017年会的报告。
J Rheumatol Suppl. 2018 Jun;94:11-16. doi: 10.3899/jrheum.180131.
4
Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations.静脉注射戈利木单抗治疗多关节型幼年特发性关节炎和幼年银屑病关节炎患者,以及皮下注射乌司奴单抗治疗幼年银屑病关节炎患者:来自成人和临近儿科人群研究的外推数据。
Paediatr Drugs. 2022 Nov;24(6):699-714. doi: 10.1007/s40272-022-00533-y. Epub 2022 Sep 28.
5
Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?青少年银屑病关节炎患者与非银屑病青少年特发性关节炎患者的比较:他们有多大差异?
J Rheumatol. 2009 Sep;36(9):2033-41. doi: 10.3899/jrheum.080674. Epub 2009 Jul 31.
6
Occurrence and Risk Factors of Uveitis in Juvenile Psoriatic Arthritis: Data From a Population-based Nationwide Study in Germany.幼年特发性关节炎相关葡萄膜炎的发病情况及危险因素:来自德国一项基于人群的全国性研究的数据。
J Rheumatol. 2022 Jul;49(7):719-724. doi: 10.3899/jrheum.210755. Epub 2022 Jan 15.
7
New Insights on Juvenile Psoriatic Arthritis.青少年银屑病关节炎的新见解
Front Pediatr. 2022 May 26;10:884727. doi: 10.3389/fped.2022.884727. eCollection 2022.
8
Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?幼年特发性关节炎(JPsA):伴银屑病的幼年关节炎?
Pediatr Rheumatol Online J. 2013 Mar 15;11(1):11. doi: 10.1186/1546-0096-11-11.
9
The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.CARRA注册中心的青少年银屑病关节炎队列:临床特征、分类及转归
J Rheumatol. 2017 Mar;44(3):342-351. doi: 10.3899/jrheum.160717. Epub 2017 Feb 1.
10
The impact of psoriasis on wellbeing and clinical outcomes in juvenile psoriatic arthritis.银屑病对青少年银屑病关节炎患者的健康相关生活质量和临床结局的影响。
Rheumatology (Oxford). 2024 May 2;63(5):1273-1280. doi: 10.1093/rheumatology/kead370.

引用本文的文献

1
Juvenile idiopathic arthritis and associated uveitis: A review of pathogenesis, diagnosis, and management.青少年特发性关节炎及相关葡萄膜炎:发病机制、诊断与管理综述
Saudi J Ophthalmol. 2025 Jan 2;39(1):31-40. doi: 10.4103/sjopt.sjopt_153_24. eCollection 2025 Jan-Mar.
2
What have we learned from long-term studies in juvenile idiopathic arthritis? - Prediction, classification, transition.我们从青少年特发性关节炎的长期研究中学到了什么?——预测、分类、转变。
Pediatr Rheumatol Online J. 2025 Feb 19;23(1):18. doi: 10.1186/s12969-025-01070-x.
3
Characteristics That Predict Psoriatic Arthritis by the Classification Criteria for Psoriatic Arthritis in Patients With Juvenile Idiopathic Arthritis 18 Years After Disease Onset.

本文引用的文献

1
Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations.静脉注射戈利木单抗治疗多关节型幼年特发性关节炎和幼年银屑病关节炎患者,以及皮下注射乌司奴单抗治疗幼年银屑病关节炎患者:来自成人和临近儿科人群研究的外推数据。
Paediatr Drugs. 2022 Nov;24(6):699-714. doi: 10.1007/s40272-022-00533-y. Epub 2022 Sep 28.
2
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial.司库奇尤单抗治疗附着点相关关节炎和幼年特发性关节炎的随机、双盲、安慰剂对照、停药、3 期临床试验。
Ann Rheum Dis. 2023 Jan;82(1):154-160. doi: 10.1136/ard-2022-222849. Epub 2022 Aug 12.
3
根据幼年特发性关节炎患者发病18年后的银屑病关节炎分类标准预测银屑病关节炎的特征。
ACR Open Rheumatol. 2025 Jan;7(1):e11758. doi: 10.1002/acr2.11758. Epub 2024 Dec 10.
4
Application of the new classification proposal for juvenile idiopathic arthritis of the pediatric rheumatology international trials organization in a group of Mexican patients.儿科风湿病国际试验组织关于青少年特发性关节炎的新分类建议在一组墨西哥患者中的应用。
Front Pediatr. 2024 Nov 7;12:1476257. doi: 10.3389/fped.2024.1476257. eCollection 2024.
5
Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022.2001年至2022年美国商业保险儿童中用于幼年特发性关节炎的改善病情抗风湿药新使用趋势
Arthritis Rheumatol. 2025 Apr;77(4):468-476. doi: 10.1002/art.43041. Epub 2024 Dec 10.
6
Treatment of non-systemic juvenile idiopathic arthritis.非系统性幼年特发性关节炎的治疗。
Nat Rev Rheumatol. 2024 Mar;20(3):170-181. doi: 10.1038/s41584-024-01079-8. Epub 2024 Feb 6.
7
Pediatric psoriasis: Understanding pathological conditions and advances in treatment.儿童银屑病:了解病理状况和治疗进展。
J Dermatol. 2024 Feb;51(2):185-195. doi: 10.1111/1346-8138.17049. Epub 2023 Dec 17.
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.2021 年美国风湿病学会幼年特发性关节炎治疗指南:寡关节型、颞下颌关节炎和全身型幼年特发性关节炎的治疗方法。
Arthritis Rheumatol. 2022 Apr;74(4):553-569. doi: 10.1002/art.42037. Epub 2022 Mar 1.
4
Juvenile idiopathic arthritis.幼年特发性关节炎
Nat Rev Dis Primers. 2022 Jan 27;8(1):5. doi: 10.1038/s41572-021-00332-8.
5
Occurrence and Risk Factors of Uveitis in Juvenile Psoriatic Arthritis: Data From a Population-based Nationwide Study in Germany.幼年特发性关节炎相关葡萄膜炎的发病情况及危险因素:来自德国一项基于人群的全国性研究的数据。
J Rheumatol. 2022 Jul;49(7):719-724. doi: 10.3899/jrheum.210755. Epub 2022 Jan 15.
6
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.托法替尼治疗幼年特发性关节炎:一项双盲、安慰剂对照、撤药阶段 3 随机试验。
Lancet. 2021 Nov 27;398(10315):1984-1996. doi: 10.1016/S0140-6736(21)01255-1. Epub 2021 Nov 9.
7
Psoriatic arthritis.银屑病关节炎。
Nat Rev Dis Primers. 2021 Aug 12;7(1):59. doi: 10.1038/s41572-021-00293-y.
8
Psoriatic arthritis in childhood: A commentary on the controversy.儿童银屑病关节炎:争议述评。
Clin Immunol. 2020 May;214:108396. doi: 10.1016/j.clim.2020.108396. Epub 2020 Mar 27.
9
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr study.乌司奴单抗治疗儿童患者(≥6至<12岁)中重度斑块状银屑病:开放标签CADMUS Jr研究的疗效、安全性、药代动力学及生物标志物结果
Br J Dermatol. 2020 Oct;183(4):664-672. doi: 10.1111/bjd.19018. Epub 2020 May 10.
10
Pediatric psoriatic arthritis: a population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities.儿童银屑病关节炎:一项基于人群的队列研究,探讨发病风险因素及后续炎症性合并症风险
J Psoriasis Psoriatic Arthritis. 2018 Oct;3(4):131-136. doi: 10.1177/2475530318799072. Epub 2018 Sep 18.